BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

444 related articles for article (PubMed ID: 16418982)

  • 1. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap.
    Menyhay SZ; Maki DG
    Infect Control Hosp Epidemiol; 2006 Jan; 27(1):23-7. PubMed ID: 16418982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors.
    Menyhay SZ; Maki DG
    Am J Infect Control; 2008 Dec; 36(10):S174.e1-5. PubMed ID: 19084153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
    Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
    J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequate disinfection of a split-septum needleless intravascular connector with a 5-second alcohol scrub.
    Rupp ME; Yu S; Huerta T; Cavalieri RJ; Alter R; Fey PD; Van Schooneveld T; Anderson JR
    Infect Control Hosp Epidemiol; 2012 Jul; 33(7):661-5. PubMed ID: 22669226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The coated antiseptic tip (CAT) syringe.
    Mariyaselvam M; Hodges E; Richardson J; Steel A; Moondi P; Young P
    J Med Eng Technol; 2015; 39(5):259-63. PubMed ID: 25970696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disinfection of needleless connectors with chlorhexidine-alcohol provides long-lasting residual disinfectant activity.
    Hong H; Morrow DF; Sandora TJ; Priebe GP
    Am J Infect Control; 2013 Aug; 41(8):e77-9. PubMed ID: 23394859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of needleless connectors on catheter-related bloodstream infections.
    Btaiche IF; Kovacevich DS; Khalidi N; Papke LF
    Am J Infect Control; 2011 May; 39(4):277-83. PubMed ID: 21256629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of universal disinfectant cap implementation on central line-associated bloodstream infections.
    Merrill KC; Sumner S; Linford L; Taylor C; Macintosh C
    Am J Infect Control; 2014 Dec; 42(12):1274-7. PubMed ID: 25465256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro evaluation of disinfection protocols used for needleless connectors of central venous catheters.
    Mazher MA; Kallen A; Edwards JR; Donlan RM
    Lett Appl Microbiol; 2013 Oct; 57(4):282-7. PubMed ID: 23710651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbiologic evaluation of needleless and needle-access devices.
    Arduino MJ; Bland LA; Danzig LE; McAllister SK; Aguero SM
    Am J Infect Control; 1997 Oct; 25(5):377-80. PubMed ID: 9343619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of microbial contamination on the outer surface of needleless connectors before and after disinfection.
    Akbıyık A; Kaya S; Aksun M
    Intensive Crit Care Nurs; 2023 Aug; 77():103414. PubMed ID: 36801154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbial colonization of intravascular catheter connectors in hospitalized patients.
    Hankins R; Majorant OD; Rupp ME; Cavalieri RJ; Fey PD; Lyden E; Cawcutt KA
    Am J Infect Control; 2019 Dec; 47(12):1489-1492. PubMed ID: 31345614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A prospective clinical trial to evaluate the microbial barrier of a needleless connector.
    Casey AL; Burnell S; Whinn H; Worthington T; Faroqui MH; Elliott TS
    J Hosp Infect; 2007 Mar; 65(3):212-8. PubMed ID: 17241691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disinfection of needleless connectors to reduce
    Rocha PK; Rickard CM; Gales AC; Sincero TCM; Ray-Barruel G; Ullman AJ; Dalcin CB; Pedreira MLG
    Br J Nurs; 2022 Oct; 31(19):S26-S31. PubMed ID: 36306235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disinfection of vascular catheter connectors that are protected by antiseptic caps is unnecessary.
    Fillman KM; Ryder JH; Brailita DM; Rupp ME; Cavalieri RJ; Fey PD; Lyden ER; Hankins RJ
    Infect Control Hosp Epidemiol; 2024 Jan; 45(1):35-39. PubMed ID: 37466074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective clinical study to investigate the microbial contamination ofa needleless connector.
    Seymour VM; Dhallu TS; Moss HA; Tebbs SE; Elliot TS
    J Hosp Infect; 2000 Jun; 45(2):165-8. PubMed ID: 10860694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Challenges in reducing the risk of infection when accessing vascular catheters.
    Greene ES
    J Hosp Infect; 2021 Jul; 113():130-144. PubMed ID: 33713758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microbiological comparison of a silver-coated and a non-coated needleless intravascular connector in clinical use.
    Casey AL; Karpanen TJ; Nightingale P; Cook M; Elliott TS
    J Hosp Infect; 2012 Apr; 80(4):299-303. PubMed ID: 22341495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calibration of optimal use parameters for an ultraviolet light-emitting diode in eliminating bacterial contamination on needleless connectors.
    Hutchens MP; Drennan SL; Cambronne ED
    J Appl Microbiol; 2015 Jun; 118(6):1298-305. PubMed ID: 25801979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A mixed-methods evaluation on the efficacy and perceptions of needleless connector disinfectants.
    Roberts SC; Hendrix CA; Edwards LM; Feinn RS; Martinello RA; Murray TS
    Infect Control Hosp Epidemiol; 2023 Feb; 44(2):230-233. PubMed ID: 35387702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.